CN103405758B - 一种应用脐血单状核细胞制备肿瘤特异性dc疫苗的方法 - Google Patents
一种应用脐血单状核细胞制备肿瘤特异性dc疫苗的方法 Download PDFInfo
- Publication number
- CN103405758B CN103405758B CN201310310461.4A CN201310310461A CN103405758B CN 103405758 B CN103405758 B CN 103405758B CN 201310310461 A CN201310310461 A CN 201310310461A CN 103405758 B CN103405758 B CN 103405758B
- Authority
- CN
- China
- Prior art keywords
- cell
- tumor
- blood
- vaccine
- ucb
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 206010028980 Neoplasm Diseases 0.000 title claims abstract description 42
- 229940029030 dendritic cell vaccine Drugs 0.000 title claims abstract description 24
- 238000000034 method Methods 0.000 title claims abstract description 14
- 210000004700 fetal blood Anatomy 0.000 title abstract description 7
- 210000005087 mononuclear cell Anatomy 0.000 title abstract description 5
- 239000002243 precursor Substances 0.000 claims abstract description 21
- 230000003321 amplification Effects 0.000 claims abstract description 11
- 238000003199 nucleic acid amplification method Methods 0.000 claims abstract description 11
- 230000006698 induction Effects 0.000 claims abstract description 8
- 210000004027 cell Anatomy 0.000 claims description 51
- 210000004369 blood Anatomy 0.000 claims description 22
- 239000008280 blood Substances 0.000 claims description 22
- 238000002360 preparation method Methods 0.000 claims description 13
- 210000004881 tumor cell Anatomy 0.000 claims description 13
- 210000003754 fetus Anatomy 0.000 claims description 12
- UZOVYGYOLBIAJR-UHFFFAOYSA-N 4-isocyanato-4'-methyldiphenylmethane Chemical compound C1=CC(C)=CC=C1CC1=CC=C(N=C=O)C=C1 UZOVYGYOLBIAJR-UHFFFAOYSA-N 0.000 claims description 11
- 239000001963 growth medium Substances 0.000 claims description 11
- 210000001519 tissue Anatomy 0.000 claims description 11
- 239000013592 cell lysate Substances 0.000 claims description 10
- 239000007788 liquid Substances 0.000 claims description 10
- 230000001939 inductive effect Effects 0.000 claims description 9
- 102000004169 proteins and genes Human genes 0.000 claims description 9
- 108090000623 proteins and genes Proteins 0.000 claims description 9
- 238000011002 quantification Methods 0.000 claims description 9
- 238000000926 separation method Methods 0.000 claims description 9
- 238000005406 washing Methods 0.000 claims description 8
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 claims description 6
- 206010003445 Ascites Diseases 0.000 claims description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 6
- 229910000831 Steel Inorganic materials 0.000 claims description 6
- 108060008682 Tumor Necrosis Factor Proteins 0.000 claims description 6
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 claims description 6
- 210000004381 amniotic fluid Anatomy 0.000 claims description 6
- 210000000481 breast Anatomy 0.000 claims description 6
- 239000006285 cell suspension Substances 0.000 claims description 6
- 230000000249 desinfective effect Effects 0.000 claims description 6
- 230000001605 fetal effect Effects 0.000 claims description 6
- 239000006166 lysate Substances 0.000 claims description 6
- 239000010959 steel Substances 0.000 claims description 6
- 239000000725 suspension Substances 0.000 claims description 6
- 210000003954 umbilical cord Anatomy 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 208000030507 AIDS Diseases 0.000 claims description 3
- 108010029697 CD40 Ligand Proteins 0.000 claims description 3
- 102100032937 CD40 ligand Human genes 0.000 claims description 3
- 208000031404 Chromosome Aberrations Diseases 0.000 claims description 3
- 208000035473 Communicable disease Diseases 0.000 claims description 3
- 208000027205 Congenital disease Diseases 0.000 claims description 3
- 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 claims description 3
- 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 claims description 3
- 101000946889 Homo sapiens Monocyte differentiation antigen CD14 Proteins 0.000 claims description 3
- 108090000978 Interleukin-4 Proteins 0.000 claims description 3
- 102100035877 Monocyte differentiation antigen CD14 Human genes 0.000 claims description 3
- 208000002787 Pregnancy Complications Diseases 0.000 claims description 3
- 208000006399 Premature Obstetric Labor Diseases 0.000 claims description 3
- 208000003107 Premature Rupture Fetal Membranes Diseases 0.000 claims description 3
- 206010036600 Premature labour Diseases 0.000 claims description 3
- 230000001464 adherent effect Effects 0.000 claims description 3
- 238000010241 blood sampling Methods 0.000 claims description 3
- 210000000988 bone and bone Anatomy 0.000 claims description 3
- 201000011510 cancer Diseases 0.000 claims description 3
- 238000010790 dilution Methods 0.000 claims description 3
- 239000012895 dilution Substances 0.000 claims description 3
- 230000009977 dual effect Effects 0.000 claims description 3
- 239000000284 extract Substances 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 208000006454 hepatitis Diseases 0.000 claims description 3
- 231100000283 hepatitis Toxicity 0.000 claims description 3
- 208000015181 infectious disease Diseases 0.000 claims description 3
- 210000004698 lymphocyte Anatomy 0.000 claims description 3
- 210000001006 meconium Anatomy 0.000 claims description 3
- 239000002609 medium Substances 0.000 claims description 3
- 230000002093 peripheral effect Effects 0.000 claims description 3
- 210000002826 placenta Anatomy 0.000 claims description 3
- 230000003169 placental effect Effects 0.000 claims description 3
- 230000035935 pregnancy Effects 0.000 claims description 3
- 208000012113 pregnancy disease Diseases 0.000 claims description 3
- 208000026440 premature labor Diseases 0.000 claims description 3
- 230000029058 respiratory gaseous exchange Effects 0.000 claims description 3
- 229920006395 saturated elastomer Polymers 0.000 claims description 3
- 238000003860 storage Methods 0.000 claims description 3
- 208000006379 syphilis Diseases 0.000 claims description 3
- 210000003606 umbilical vein Anatomy 0.000 claims description 3
- 239000013589 supplement Substances 0.000 claims 1
- 239000000427 antigen Substances 0.000 description 11
- 102000036639 antigens Human genes 0.000 description 11
- 108091007433 antigens Proteins 0.000 description 11
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- 238000002560 therapeutic procedure Methods 0.000 description 8
- 229960005486 vaccine Drugs 0.000 description 8
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- 230000001413 cellular effect Effects 0.000 description 6
- 230000003053 immunization Effects 0.000 description 6
- 238000002649 immunization Methods 0.000 description 6
- 230000003248 secreting effect Effects 0.000 description 6
- 238000011282 treatment Methods 0.000 description 6
- 102000013462 Interleukin-12 Human genes 0.000 description 5
- 108010065805 Interleukin-12 Proteins 0.000 description 5
- 210000001744 T-lymphocyte Anatomy 0.000 description 5
- 210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 5
- 238000007799 mixed lymphocyte reaction assay Methods 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 229920002307 Dextran Polymers 0.000 description 3
- 102000003814 Interleukin-10 Human genes 0.000 description 3
- 108090000174 Interleukin-10 Proteins 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000005138 cryopreservation Methods 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 210000001165 lymph node Anatomy 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 210000005259 peripheral blood Anatomy 0.000 description 3
- 239000011886 peripheral blood Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 238000002965 ELISA Methods 0.000 description 2
- 108010002616 Interleukin-5 Proteins 0.000 description 2
- 108090001005 Interleukin-6 Proteins 0.000 description 2
- 102000004889 Interleukin-6 Human genes 0.000 description 2
- 230000006044 T cell activation Effects 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 229940127219 anticoagulant drug Drugs 0.000 description 2
- 238000003501 co-culture Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000009169 immunotherapy Methods 0.000 description 2
- 230000001665 lethal effect Effects 0.000 description 2
- 230000035800 maturation Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 238000002255 vaccination Methods 0.000 description 2
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 101000934338 Homo sapiens Myeloid cell surface antigen CD33 Proteins 0.000 description 1
- 101000767631 Human papillomavirus type 16 Protein E7 Proteins 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 102100025243 Myeloid cell surface antigen CD33 Human genes 0.000 description 1
- 208000015634 Rectal Neoplasms Diseases 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 102000004887 Transforming Growth Factor beta Human genes 0.000 description 1
- 108090001012 Transforming Growth Factor beta Proteins 0.000 description 1
- 230000000735 allogeneic effect Effects 0.000 description 1
- 210000000612 antigen-presenting cell Anatomy 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 201000008275 breast carcinoma Diseases 0.000 description 1
- 229940030156 cell vaccine Drugs 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 210000003109 clavicle Anatomy 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000002784 cytotoxicity assay Methods 0.000 description 1
- 231100000263 cytotoxicity test Toxicity 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011337 individualized treatment Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 206010038038 rectal cancer Diseases 0.000 description 1
- 201000001275 rectum cancer Diseases 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310310461.4A CN103405758B (zh) | 2013-07-23 | 2013-07-23 | 一种应用脐血单状核细胞制备肿瘤特异性dc疫苗的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310310461.4A CN103405758B (zh) | 2013-07-23 | 2013-07-23 | 一种应用脐血单状核细胞制备肿瘤特异性dc疫苗的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103405758A CN103405758A (zh) | 2013-11-27 |
CN103405758B true CN103405758B (zh) | 2014-12-10 |
Family
ID=49598831
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310310461.4A Active CN103405758B (zh) | 2013-07-23 | 2013-07-23 | 一种应用脐血单状核细胞制备肿瘤特异性dc疫苗的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103405758B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109954133A (zh) * | 2017-12-22 | 2019-07-02 | 上海市浦东医院(复旦大学附属浦东医院) | 一种肿瘤疫苗及其制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102091327A (zh) * | 2010-12-27 | 2011-06-15 | 蔡建辉 | 一种负载自体肿瘤相关全抗原的树突状细胞疫苗的制备方法 |
CN102657853A (zh) * | 2012-04-27 | 2012-09-12 | 蔡建辉 | 初始t细胞来源的肿瘤特异性杀伤细胞的制备及其应用 |
CN102676455A (zh) * | 2012-05-16 | 2012-09-19 | 北京和泽普瑞生物科技有限公司 | 脐带血来源的树突状细胞及树突状细胞疫苗的制备方法 |
-
2013
- 2013-07-23 CN CN201310310461.4A patent/CN103405758B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102091327A (zh) * | 2010-12-27 | 2011-06-15 | 蔡建辉 | 一种负载自体肿瘤相关全抗原的树突状细胞疫苗的制备方法 |
CN102657853A (zh) * | 2012-04-27 | 2012-09-12 | 蔡建辉 | 初始t细胞来源的肿瘤特异性杀伤细胞的制备及其应用 |
CN102676455A (zh) * | 2012-05-16 | 2012-09-19 | 北京和泽普瑞生物科技有限公司 | 脐带血来源的树突状细胞及树突状细胞疫苗的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN103405758A (zh) | 2013-11-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103405759B (zh) | 一种应用脐血cd34+细胞制备肿瘤特异性dc疫苗方法 | |
CN105176927A (zh) | 一种细胞毒性增强的高效靶向杀伤nk/cik细胞的制备方法 | |
CN103599528B (zh) | 人树突状细胞疫苗的制备方法 | |
CN104087551B (zh) | 一种体外分离培养人的表皮细胞的方法 | |
JP6711757B2 (ja) | 間葉系幹細胞から誘導された万能幹細胞を利用して肝細胞に分化させる方法 | |
CN104762257A (zh) | 一种从脐带制备间充质干细胞的方法 | |
CN106177931A (zh) | 免疫检测点双阻断ctl高效率杀伤细胞制剂的制备方法 | |
CN103881975B (zh) | 人前列腺癌细胞及其原代分离培养和传代培养方法与用途 | |
CN108379569A (zh) | 高效荷载肿瘤抗原的dc疫苗及其诱导扩增肿瘤抗原特异性ctl的方法 | |
CN105112371A (zh) | 脐带血单个核细胞来源的dc-cik细胞制取方法及制剂 | |
CN109251890A (zh) | 一种高效提取子宫内膜间充质干细胞的方法及其应用 | |
CN103396991A (zh) | 一种快速高效扩增肿瘤浸润性淋巴细胞的方法 | |
CN103405758B (zh) | 一种应用脐血单状核细胞制备肿瘤特异性dc疫苗的方法 | |
CN107354130A (zh) | 一种人胎盘绒毛膜间充质干细胞分离方法 | |
CN103451150B (zh) | 一种胎盘源母体间充质干细胞的制备方法 | |
CN109402057A (zh) | 一种负载肿瘤细胞外泌体的dc-ctl细胞的培养方法 | |
CN103740643B (zh) | 一种mhc限制性杀伤t细胞的体外诱导培养方法 | |
JP6711756B2 (ja) | 間葉系幹細胞から誘導された万能幹細胞を利用して脂肪細胞に分化させる方法 | |
CN103305453A (zh) | 一种脐带间充质干细胞的微载体培养系统 | |
CN114807031A (zh) | 一种人外周血免疫细胞库和干细胞库的构建方法 | |
CN113564109A (zh) | 一种经血间充质干细胞的制备方法 | |
CN110484491B (zh) | 羊膜和羊水来源的内皮祖细胞获取方法及其纯化培养方法 | |
CN103602634B (zh) | Dc细胞的制备方法及其在制备抗肿瘤细胞制剂中的应用 | |
CN106676063A (zh) | 一种人羊膜间充质干细胞的分离培养方法 | |
CN105441381A (zh) | 体外诱导人脂肪间充质干细胞向有功能肝细胞分化的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
ASS | Succession or assignment of patent right |
Free format text: FORMER OWNER: LI CAIZHEN Effective date: 20131105 Owner name: CAI YING Free format text: FORMER OWNER: CAI JIANHUI Effective date: 20131105 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Cai Jianhui Inventor after: Xing Hongli Inventor after: Cui Naipeng Inventor after: Yue Xiang Inventor before: Cai Jianhui Inventor before: Liu Gang Inventor before: Gao Fei |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: CAI JIANHUI LIU GANG GAO FEI TO: CAI JIANHUI XING HONGLI CUI NAIPENG YUE XIANG |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20131105 Address after: 050000 Heping West Road, Hebei, Shijiazhuang, No. 348 Applicant after: Cai Ying Address before: 050000 Heping West Road, Hebei, Shijiazhuang, No. 348 Applicant before: Cai Jianhui Applicant before: Li Caizhen |
|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: HEBEI LITONGKANG BIOLOGICAL TECHNOLOGY CO., LTD. Free format text: FORMER OWNER: CAI YING Effective date: 20150413 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Cai Jianhui Inventor after: Xing Hongli Inventor after: Cui Naipeng Inventor after: Li Hanlin Inventor before: Cai Jianhui Inventor before: Xing Hongli Inventor before: Cui Naipeng Inventor before: Yue Xiang |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: CAI JIANHUI XING HONGLI CUI NAIPENG YUE XIANG TO: CAI JIANHUI XING HONGLI CUI NAIPENG LI HANLIN |
|
TR01 | Transfer of patent right |
Effective date of registration: 20150413 Address after: 050000 No. 219, Qinshan street, hi tech Zone, Hebei, Shijiazhuang 1-206 Patentee after: HEBEI LITONGKANG BIOTECHNOLOGY CO.,LTD. Address before: 050000 Heping West Road, Hebei, Shijiazhuang, No. 348 Patentee before: Cai Ying |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160727 Address after: 050000 Changjiang Road, high tech Zone, Hebei, Shijiazhuang, China, 238 Patentee after: Hebei Hua Feng Kang Biotechnology Co.,Ltd. Address before: The 050000 street in Hebei Province in Shijiazhuang high tech Development Zone No. 219 1-206 Patentee before: HEBEI LITONGKANG BIOTECHNOLOGY CO.,LTD. |
|
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: 050000 Changjiang Road, high tech Zone, Hebei, Shijiazhuang, China, 238 Patentee after: Hebei Tong Ling Rong Biotechnology Co.,Ltd. Address before: 050000 Changjiang Road, high tech Zone, Hebei, Shijiazhuang, China, 238 Patentee before: Hebei Hua Feng Kang Biotechnology Co.,Ltd. |
|
CB03 | Change of inventor or designer information |
Inventor after: Cai Shoufeng Inventor after: Cai Ziqi Inventor after: He Huijuan Inventor after: Cui Naipeng Inventor after: Yuan Can Inventor before: Cai Jianhui Inventor before: Xing Hongli Inventor before: Cui Naipeng Inventor before: Li Hanlin |
|
CB03 | Change of inventor or designer information | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180108 Address after: No. 219, Taishan street, Shijiazhuang high tech Zone, Hebei Province Patentee after: HEBEI NONGFOYU BIOLOGY TECHNOLOGY Co.,Ltd. Address before: 050000 Changjiang Road, high tech Zone, Hebei, Shijiazhuang, China, 238 Patentee before: Hebei Tong Ling Rong Biotechnology Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20211208 Address after: 050000 floor 1, building 1, Hongchang Industrial Park, No. 238 Changjiang Avenue, Shijiazhuang high tech Zone, Shijiazhuang, Hebei Province Patentee after: Nongfuyu pharmaceutical Hebei Co.,Ltd. Address before: 050000 no.219, Taishan street, high tech Zone, Shijiazhuang City, Hebei Province Patentee before: HEBEI NONGFOYU BIOLOGY TECHNOLOGY Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
CP01 | Change in the name or title of a patent holder |
Address after: 050000 floor 1, building 1, Hongchang Industrial Park, No. 238 Changjiang Avenue, Shijiazhuang high tech Zone, Shijiazhuang, Hebei Province Patentee after: Nongfuyu pharmaceutical Hebei Co.,Ltd. Address before: 050000 floor 1, building 1, Hongchang Industrial Park, No. 238 Changjiang Avenue, Shijiazhuang high tech Zone, Shijiazhuang, Hebei Province Patentee before: Nongfuyu pharmaceutical Hebei Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder | ||
TR01 | Transfer of patent right |
Effective date of registration: 20231012 Address after: Room 2024, Hebei Publishing Media Creative Center, No. 19 Yuanboyuan Street, Zhengding District, China (Hebei) Free Trade Pilot Zone, Shijiazhuang City, Hebei Province, 050899 Patentee after: Yuetenong biotechnology Hebei Co.,Ltd. Address before: 050000 floor 1, building 1, Hongchang Industrial Park, No. 238 Changjiang Avenue, Shijiazhuang high tech Zone, Shijiazhuang, Hebei Province Patentee before: Nongfuyu pharmaceutical Hebei Co.,Ltd. |
|
TR01 | Transfer of patent right |